Key Takeaways

• Women vaccinated against HPV had a 37% lower risk of developing high-grade vulvovaginal lesions compared with unvaccinated women. [MedPage Today]
• This increased to 55% for those vaccinated between the ages of 10 and 16, emphasizing the benefits of early immunization.
• Benefits were observed even in women who received only one dose of the vaccine.

Women vaccinated against human papillomavirus (HPV) had a significantly lower risk of high-grade vulvovaginal lesions, a large cohort study from Sweden showed.

Vaccinated women had a 37% lower risk of developing lesions, which increased to 55% among women who were vaccinated at younger ages. The protection applied equally to vulvar and vaginal lesions. The vaccinated cohort included women who received as few as one of the recommended three doses of the quadrivalent vaccine.

Risk was reduced by 37-55% in vaccinated versus unvaccinated women in Sweden

More>

Check out IOMC's Upcoming Programs: 

1.14.2026  Webinar: From Awareness to Action: Increasing HPV Vaccine Referrals in Dental Settings. More details and to Register> 

2.17.2026 Webinar: Addressing the Health Needs of Justice Involved Individuals during Reentry. More details and to Register> 

Sponsors: Interested in sponsoring a webinar or program? Contact us at sponsorship@iomc.org. 

###